THE SUPPORT SYSTEM

Support the system,
not the signal.

A research-led field guide to cognition, cellular energy, membranes, stress resilience, and longer-horizon brain health—what may help, who was actually studied, what remains hypothetical, and what can go wrong.

16 INGREDIENT PROFILES6 BIOLOGICAL SYSTEMSPOPULATION-SPECIFIC EVIDENCEINTERACTION GUIDE

01 · THE MAP

Six systems behind
the cognition conversation.

These systems overlap, but “participates in a pathway” does not mean “improves cognition”—and neither means “amplifies a psychedelic.” Direct human evidence for these combinations is absent.

◌

Membranes & signalling

DHA is a structural membrane lipid. Magnesium is a broad enzyme cofactor. Together they describe baseline cellular infrastructure—not an acute enhancer.

OMEGA-3MAGNESIUM

⌁

Cofactors & methylation

B vitamins participate in energy metabolism, one-carbon metabolism, and neurotransmitter synthesis. Correcting deficiency matters more than adding excess.

B-COMPLEXNIACINVITAMIN D

✦

Plasticity hypothesis

Lion’s mane compounds influence neurotrophic signalling in preclinical models. Human cognition studies are small and mixed; synergy with psychedelics is unproven.

LION’S MANE

≈

Calm attention & memory

L-theanine has modest attention and stress data. Bacopa has mixed longer-term cognition data and proposed cholinergic effects. Neither is an instant reset.

L-THEANINEBACOPA

↯

Cellular bioenergetics

Creatine buffers ATP availability in brain and muscle. Cognitive signals are most plausible under energetic stress, sleep loss, low intake, or higher demand—not as universal stimulation.

CREATINEMAGNESIUMB VITAMINS

◎

Membrane & cholinergic biology

Citicoline, choline, phosphatidylserine, and DHA intersect with phospholipid or acetylcholine biology. Human outcomes depend heavily on age, baseline status, and formulation.

CITICOLINEPHOSPHATIDYLSERINEOMEGA-3

02 · INGREDIENT INDEX

One ingredient.
One honest profile.

Study ranges are context, not personalized directions. Product quality, extraction method, baseline status, medications, population, and medical history all change the answer.

START HERE

Correct the constraint

Sleep, diet, deficiency, medication effects, and health conditions usually deserve attention before a nootropic stack. The most defensible supplement is often the one correcting a real gap.

CONTEXT MATTERS

Match the population

A benefit in sleep-deprived adults, older adults with memory complaints, or people with MCI cannot be silently translated into a healthy 25-year-old.

FORMULATION MATTERS

Extracts are not interchangeable

Standardized bacopa, lion’s mane fruiting-body powder, erinacine-enriched mycelium, and bioavailable curcumin are materially different interventions.

OUTCOME MATTERS

A biomarker is not a benefit

Changing cortisol, BDNF, blood choline, or antioxidant markers can support a mechanism without proving better memory, attention, mood, or long-term brain health.

Lion’s Mane

Hericium erinaceus

EMERGING

A culinary mushroom studied for cognition and neurotrophic signalling. Its reputation is ahead of the human evidence.

MECHANISM: Hericenones and erinacines are investigated for NGF-related signalling, primarily in cell and animal work.
POSSIBLE ROLE: Longer-term cognitive or plasticity support—not an acute potentiator.
EVIDENCE: Small controlled trials in mild cognitive impairment and limited healthy-adult pilot studies; formulations vary.
WATCH: Mushroom allergy, gastrointestinal effects, and uncertain extract equivalence. Avoid implying every powder contains studied actives.

Omega-3

DHA + EPA

FOUNDATIONAL

DHA is a major neuronal membrane component; EPA participates in inflammatory signalling. This is baseline nutrition, not a same-day stack effect.

MECHANISM: Membrane fluidity, lipid mediators, and broad cardiovascular and inflammatory biology.
POSSIBLE ROLE: A steady nutritional foundation when dietary oily-fish intake is low.
EVIDENCE: Established nutrient biology; cognitive benefits from supplements vary by population and baseline status.
WATCH: Fish/shellfish allergy, product oxidation, gastrointestinal effects, and anticoagulant or antiplatelet therapy.

Niacin

Vitamin B3 · nicotinic acid

DEBATED

A precursor for NAD/NADP metabolism and the flushing component of the popular “Stamets stack.” The flush is not proof of delivery to the nervous system.

MECHANISM: Essential coenzyme biology. Nicotinic acid causes prostaglandin-mediated skin vasodilation and flushing.
POSSIBLE ROLE: Theoretical addition in one branded protocol; no clinical evidence that it drives compounds toward peripheral nerves.
EVIDENCE: Established vitamin function; psychedelic-stack synergy is untested.
WATCH: Flushing, itching, dizziness, glucose and uric-acid effects, liver injury at high or sustained doses, and statin interactions.

B-Complex

B6 · folate · B12 and peers

CONDITIONAL

A group of metabolic cofactors frequently marketed as “energy.” Benefits are most plausible when intake or absorption is inadequate.

MECHANISM: Amino-acid metabolism, methylation, red-blood-cell biology, and enzymatic steps used in neurotransmitter synthesis.
POSSIBLE ROLE: Correct a documented or likely gap rather than indiscriminately megadose.
EVIDENCE: Deficiency correction is established; extra intake does not automatically create extra cognition or energy.
WATCH: Chronic high-dose B6 can cause neuropathy. Folate can mask hematologic signs of B12 deficiency.

Magnesium

Essential mineral

FOUNDATIONAL

A cofactor in hundreds of reactions, including energy metabolism and normal nerve and muscle function. Form matters mainly for tolerance and absorption.

MECHANISM: ATP-related enzymatic work, ion-channel function, neuromuscular signalling, and normal NMDA-receptor regulation.
POSSIBLE ROLE: Address inadequate intake; some people prefer evening use because certain forms feel calming.
EVIDENCE: Essential physiology is established. Claims that one form uniquely enters the brain or amplifies a stack need more evidence.
WATCH: Diarrhea, kidney impairment, and reduced absorption of some antibiotics, bisphosphonates, and thyroid medication when taken too close together.

Vitamin D3

Cholecalciferol

STATUS-BASED

A hormone-like vitamin involved in calcium regulation, immune biology, and many tissues. Blood status is more informative than season-based guesswork.

MECHANISM: Vitamin-D receptor signalling and calcium/phosphate homeostasis.
POSSIBLE ROLE: Correct insufficiency with a clinician-informed dose and periodic reassessment.
EVIDENCE: Deficiency correction is established; mood and cognition results are inconsistent in people who are already sufficient.
WATCH: Excess can cause hypercalcemia and kidney injury. Extra caution with kidney disease, granulomatous disease, and certain diuretics.

L-Theanine

Tea-derived amino acid

MODEST

A non-protein amino acid studied for attention, stress, and sleep. Effects are subtle and trials are generally small.

MECHANISM: Glutamate-related signalling and changes in cortical oscillatory activity are proposed; the full human mechanism is unresolved.
POSSIBLE ROLE: Calm attention or reducing the subjective edge of caffeine—not proven psychedelic “smoothing.”
EVIDENCE: Several randomized studies report modest attention or stress effects; sponsorship and sample size deserve attention.
WATCH: Drowsiness, blood-pressure lowering, and additive effects with sedatives or antihypertensive medication.

Bacopa Monnieri

Brahmi · standardized extracts

MIXED

An Ayurvedic herb studied over weeks—not hours—for memory and stress. Extract standardization makes comparisons difficult.

MECHANISM: Cholinergic, antioxidant, and monoaminergic mechanisms are proposed; some trials measured acetylcholinesterase-related changes.
POSSIBLE ROLE: A separate longer-term memory experiment, not a same-day add-on.
EVIDENCE: Some older trials report memory benefits; newer controlled work has found no primary cognitive advantage but possible stress effects.
WATCH: Gastrointestinal effects, fatigue, possible thyroid and cholinergic interactions, and product-to-product variability.

Creatine

Creatine monohydrate

CONTEXTUAL

A well-studied energy-buffering compound for muscle with a smaller, developing cognition literature. It is more plausible as resilience support than as a stimulant.

MECHANISM: The phosphocreatine system helps regenerate ATP during periods of higher energetic demand in muscle and brain tissue.
POSSIBLE ROLE: Energetic support under sleep loss, intense workload, aging, or lower dietary creatine intake.
EVIDENCE: The largest preregistered healthy-adult trial supported, at most, a small benefit. Smaller sleep-deprivation trials show a clearer protective signal.
WATCH: Water-weight gain and gastrointestinal effects. Kidney disease requires medical review; supplementation can also change creatinine lab values.

Citicoline

CDP-choline

TARGETED

A choline-containing intermediate used in phosphatidylcholine synthesis. Human signals are strongest in older adults or specific attention tasks—not universal enhancement.

MECHANISM: Provides choline and cytidine-derived substrates used in membrane phospholipid synthesis and cholinergic biology.
POSSIBLE ROLE: A targeted memory experiment in age-associated memory complaints, or an attention-focused trial with controlled conditions.
EVIDENCE: A 12-week trial in older adults found improvements in secondary episodic and composite-memory outcomes; industry involvement should temper certainty.
WATCH: Headache, restlessness, gastrointestinal effects, and additive cholinergic effects. Citicoline is not interchangeable with ordinary choline salts.

Phosphatidylserine

Membrane phospholipid

MIXED

A structural phospholipid concentrated on the inner side of cell membranes. The mechanism is plausible; controlled cognitive outcomes remain inconsistent.

MECHANISM: Contributes to membrane organization, signalling, vesicle biology, and recognition of cells undergoing programmed death.
POSSIBLE ROLE: A longer-horizon, age-related memory experiment—not acute focus support.
EVIDENCE: Some subgroup and combination trials report benefit, while a 120-person age-associated-memory trial found no effect at 300 or 600 mg.
WATCH: Soy or sunflower source, combination formulas, and attached fatty acids complicate comparisons. Gastrointestinal effects and insomnia are possible.

Curcumin

Turmeric-derived polyphenols

FORMULATION-SPECIFIC

A signalling-active polyphenol with poor natural absorption. Positive cognitive trials use specialized formulations that cannot be generalized to culinary turmeric.

MECHANISM: Influences inflammatory, oxidative, and cell-signalling networks; proposed brain effects remain broader than any single pathway.
POSSIBLE ROLE: A separate longer-term trial when inflammatory health is also relevant—not a same-day cognitive enhancer.
EVIDENCE: Small randomized trials in older adults report working-memory or mood signals, but samples are small and products highly specific.
WATCH: Gallbladder disease, bleeding-risk medication, gastrointestinal effects, and iron absorption. Highly bioavailable products have been linked to liver injury.

Rhodiola Rosea

Standardized root extract

CONFLICTING

An adaptogenic herb best framed around fatigue under stress, not direct memory enhancement. Extract standardization is central to interpreting the literature.

MECHANISM: Stress-response, monoamine, and hypothalamic-pituitary-adrenal signalling are proposed; human mechanistic certainty is limited.
POSSIBLE ROLE: Short-term mental-fatigue support during demanding periods, tested separately from stimulants.
EVIDENCE: Older standardized-extract trials reported attention and fatigue benefits; a rigorous nursing-student trial favored placebo on fatigue outcomes.
WATCH: Activation, insomnia, agitation, bipolar-spectrum vulnerability, and psychiatric-medication interactions warrant caution.

Ashwagandha

Withania somnifera

STRESS-FIRST

Evidence is more credible for short-term stress or insomnia outcomes than for cognition. Better sleep can improve thinking without the herb being a cognitive enhancer.

MECHANISM: HPA-axis and GABA-related effects are proposed alongside many preclinical pathways; preparations vary widely in root, leaf, and withanolide content.
POSSIBLE ROLE: A separate stress or sleep intervention when those are the actual constraints.
EVIDENCE: Direct cognition trials are generally small. Authoritative reviews consider cognitive evidence insufficient.
WATCH: Rare liver injury, thyroid and autoimmune conditions, sedation, anticonvulsants, pregnancy, breastfeeding, surgery, and multiple medication interactions.

Saffron

Crocus sativus extract

CLINICAL-POPULATION

A promising but narrow cognition candidate. Most encouraging findings come from people with Alzheimer’s disease or mild cognitive impairment—not healthy-adult nootropic use.

MECHANISM: Crocin and safranal are studied for antioxidant, inflammatory, monoaminergic, and amyloid-related effects.
POSSIBLE ROLE: Clinician-guided interest in cognitive impairment or mood—not a casual stack default.
EVIDENCE: A small 16-week Alzheimer’s trial outperformed placebo on cognitive scales; larger confirmatory trials are still needed.
WATCH: Adulteration, pregnancy, bipolar-spectrum vulnerability, allergy, and concentrated-extract interactions. Culinary saffron and studied extracts are not equivalent.

Ginkgo Biloba

Standardized leaf extract

DEPRIORITIZED

One of the best-known “memory” supplements—and a useful example of why popularity and mechanism should not outrank large human outcomes.

MECHANISM: Vascular, platelet, antioxidant, and neurotransmitter effects are proposed for standardized extracts.
POSSIBLE ROLE: Not a first-line healthy-adult cognition strategy based on current controlled evidence.
EVIDENCE: A 230-person healthy-older-adult trial found no memory benefit; a 3,069-person trial found no reduction in cognitive decline over roughly six years.
WATCH: Bleeding risk, surgery, seizure vulnerability, medication interactions, and major variability between standardized extracts and generic leaf products.

03 · BUILD WITH INTENTION

A stack is an experiment,
not a shopping list.

The cleaner the setup, the more useful the signal. Sixteen options do not belong in one regimen; multiple changes at once create multiple sources of uncertainty.

Start with baseline

Sleep, food, hydration, movement, medications, and recent lab work explain more than a complicated stack.

Choose one target

Deficiency correction, calm attention, or longer-term memory are different goals. Do not collapse them into “brain support.”

Add one variable

Introduce one ingredient at a time and hold everything else steady long enough to observe tolerance.

Log and remove

Record dose, timing, sleep, mood, focus, and side effects. Stop what does not clearly earn its place.

FOUNDATION

Food-first baseline

Omega-3 or vitamin D only when diet, status, or clinician guidance indicates a gap. Magnesium based on intake and tolerance.

CALM FOCUS

Single-variable test

L-theanine by itself, with the same caffeine and sleep conditions each test day. Do not confuse “felt calmer” with neural repair.

LONGER HORIZON

Memory experiment

Bacopa or lion’s mane as a separate multi-week trial, not both at once. Product standardization and baseline cognition matter.

ENERGY RESILIENCE

Creatine, not stimulation

Test creatine as a baseline energy-buffering intervention. Do not use it to rationalize chronic sleep loss or combine it with a new stimulant routine.

MEMBRANE / CHOLINE

Choose one lane

Citicoline and phosphatidylserine answer different questions. Select one, define a memory or attention outcome, and respect the studied population.

STRESS CONSTRAINT

Fix the cause first

Rhodiola or ashwagandha may change fatigue, stress, or sleep. Neither substitutes for recovery, and they should not be introduced together.

04 · INTERACTIONS

Check the medication,
not just the molecule.

This is a screening map, not a complete interaction database. A pharmacist can review the exact products and doses you use.

BLEEDING / ANTICOAGULANTS

Discuss higher-dose omega-3 and bacopa with a clinician if you use anticoagulants, antiplatelets, or have a bleeding disorder.

LIVER / GLUCOSE / GOUT

Niacin deserves particular caution with liver disease, diabetes, gout, heavy alcohol use, and lipid-lowering medication.

KIDNEY / MINERAL HANDLING

Magnesium and vitamin D require more care with kidney disease. Vitamin D excess can produce dangerous hypercalcemia.

ABSORPTION WINDOWS

Magnesium can bind or reduce absorption of some antibiotics, bisphosphonates, and levothyroxine. Timing separation may be required.

SEDATION / BLOOD PRESSURE

L-theanine can be additive with sedatives or blood-pressure medication. Bacopa may also cause fatigue in some people.

ALLERGY / PRODUCT QUALITY

Mushroom allergy applies to lion’s mane. Third-party testing matters for fungi, herbs, fish oils, and any concentrated extract.

LIVER / GALLBLADDER

Ashwagandha and highly bioavailable curcumin products have liver-injury reports. Curcumin also warrants caution with gallbladder or bile-duct disease.

THYROID / IMMUNE SYSTEM

Ashwagandha and bacopa deserve review with thyroid disease or thyroid medication; ashwagandha also warrants caution with autoimmune disease or immunosuppressants.

ACTIVATION / BIPOLAR RISK

Rhodiola, saffron, and stimulating combinations are poor casual experiments for anyone with bipolar-spectrum vulnerability, agitation, or unstable sleep.

05 · EVIDENCE DESK

Read past the headline.

Primary trials and authoritative nutrient references used to frame this guide. Evidence evolves; product marketing usually moves faster.

2009Lion’s mane in mild cognitive impairmentSmall randomized, double-blind, placebo-controlled trial ↗ 2023Lion’s mane in healthy young adultsSmall pilot trial; promising but preliminary ↗ NIHOmega-3 fatty acidsOffice of Dietary Supplements professional fact sheet ↗ NIHNiacinIntake, adverse effects, and medication interactions ↗ NIHVitamin B6Neuropathy risk and upper-intake guidance ↗ NIHMagnesiumPhysiology, supplemental limits, and interactions ↗ NIHVitamin DStatus, toxicity, and upper-intake guidance ↗ 2021L-theanine and cognitive functionRandomized placebo-controlled study ↗ 2025Bacopa, cognition, stress, and fatigueNo primary cognitive advantage; secondary stress findings ↗ 2023Creatine and healthy-adult cognitive performanceLargest preregistered crossover trial; small rather than dramatic signal ↗ 2026Creatine during sleep deprivationSmall randomized crossover trial under acute energetic stress ↗ 2021Citicoline and age-associated memory12-week randomized trial in adults aged 50–85 ↗ NIHCholine physiology and safetyMembranes, methyl groups, acetylcholine, and upper-intake guidance ↗ 2002Null phosphatidylserine trialNo cognitive benefit at 300 or 600 mg in age-associated memory impairment ↗ 2025Phosphatidylserine combination in MCIPositive combination trial; cannot isolate phosphatidylserine’s effect ↗ 2020Bioavailable curcumin, mood, and working memorySmall formulation-specific older-adult trial ↗ NIHTurmeric and curcumin safetyFormulation limits and liver-injury warning ↗ 2009Rhodiola in stress-related fatigueStandardized-extract trial reporting attention and fatigue signals ↗ 2014Rhodiola in nursing studentsRandomized trial whose fatigue outcomes favored placebo ↗ NIHAshwagandha usefulness and safetyStress evidence, insufficient cognition evidence, and interaction warnings ↗ 2010Saffron in mild-to-moderate Alzheimer’s diseaseSmall 16-week randomized placebo-controlled trial ↗ 2009Ginkgo and cognitive decline3,069-person trial found no slowing of cognitive decline ↗

KEEP EXPLORING

Understand the molecules
before building around them.

LUCID SCIENCE →GLOW SCIENCE →PROTOCOLS →